MK2206 overcomes the resistance of human liver cancer stem cells to sorafenib by inhibition of pAkt and upregulation of pERK
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
MK2206 overcomes the resistance of human liver cancer stem cells to sorafenib by inhibition of pAkt and upregulation of pERK
Authors
Keywords
Hepatocellular carcinoma, Liver cancer stem cells, Sorafenib, MK2206
Journal
TUMOR BIOLOGY
Volume 37, Issue 6, Pages 8047-8055
Publisher
Springer Nature
Online
2015-12-29
DOI
10.1007/s13277-015-4707-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Molecular Pathways: Novel Approaches for Improved Therapeutic Targeting of Hedgehog Signaling in Cancer Stem Cells
- (2015) Verline Justilien et al. CLINICAL CANCER RESEARCH
- Downregulation of PI3-K/Akt/PTEN pathway and activation of mitochondrial intrinsic apoptosis by Diclofenac and Curcumin in colon cancer
- (2015) Chandan Rana et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- MiR-32 induces cell proliferation, migration, and invasion in hepatocellular carcinoma by targeting PTEN
- (2015) Shi-yan Yan et al. TUMOR BIOLOGY
- Cancer stem cells: An insight and future perspective
- (2015) Sandeep Kaur et al. Journal of Cancer Research and Therapeutics
- Sorafenib-based combination as a first line treatment for advanced hepatocellular carcinoma: A systematic review of the literature
- (2014) Omar Abdel-Rahman et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- The Akt inhibitor MK-2206 enhances the cytotoxicity of paclitaxel (Taxol) and cisplatin in ovarian cancer cells
- (2014) Ying-Hsi Lin et al. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
- LY294002 Induces G0/G1 Cell Cycle Arrest and Apoptosis of Cancer Stem-like Cells from Human Osteosarcoma Via Down-regulation of PI3K Activity
- (2013) Chen Gong et al. Asian Pacific Journal of Cancer Prevention
- Miniaturized Three-Dimensional Cancer Model for Drug Evaluation
- (2013) Carrie J. Lovitt et al. ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES
- MK-2206, an Akt inhibitor, enhances carboplatinum/paclitaxel efficacy in gastric cancer cell lines
- (2013) Khaldoun Almhanna et al. CANCER BIOLOGY & THERAPY
- Identification of brain tumour initiating cells using the stem cell marker aldehyde dehydrogenase
- (2013) Seung Ah Choi et al. EUROPEAN JOURNAL OF CANCER
- Label-retaining liver cancer cells are relatively resistant to sorafenib
- (2013) Hong-Wu Xin et al. GUT
- A novel PKB/Akt inhibitor, MK-2206, effectively inhibits insulin-stimulated glucose metabolism and protein synthesis in isolated rat skeletal muscle
- (2012) Yu-Chiang Lai et al. BIOCHEMICAL JOURNAL
- BMP4 Signaling Acts via Dual-Specificity Phosphatase 9 to Control ERK Activity in Mouse Embryonic Stem Cells
- (2012) Zhongwei Li et al. Cell Stem Cell
- Sorafenib for Treatment of Hepatocellular Carcinoma: A Systematic Review
- (2012) Bingru Xie et al. DIGESTIVE DISEASES AND SCIENCES
- Hepatocellular carcinoma
- (2012) Alejandro Forner et al. LANCET
- Nonadhesive Culture System as a Model of Rapid Sphere Formation with Cancer Stem Cell Properties
- (2012) Su-Feng Chen et al. PLoS One
- Pyrvinium, a potent small molecule Wnt inhibitor, increases engraftment and inhibits lineage commitment of mesenchymal stem cells (MSCs)
- (2012) Sarika Saraswati et al. WOUND REPAIR AND REGENERATION
- Sphere-forming cell subpopulations with cancer stem cell properties in human hepatoma cell lines
- (2011) Lu Cao et al. BMC GASTROENTEROLOGY
- Targeting the PI3K/Akt/mTOR pathway in hepatocellular carcinoma
- (2011) Qian Zhou et al. Future Oncology
- The Akt Inhibitor MK2206 Synergizes, but Perifosine Antagonizes, the BRAFV600EInhibitor PLX4032 and the MEK1/2 Inhibitor AZD6244 in the Inhibition of Thyroid Cancer Cells
- (2011) Ruixin Liu et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Icaritin induces cell death in activated hepatic stellate cells through mitochondrial activated apoptosis and ameliorates the development of liver fibrosis in rats
- (2011) Jing Li et al. JOURNAL OF ETHNOPHARMACOLOGY
- Activation of Phosphatidylinositol 3-Kinase/Akt Signaling Pathway Mediates Acquired Resistance to Sorafenib in Hepatocellular Carcinoma Cells
- (2011) K.-F. Chen et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- MK-2206, a Novel Allosteric Inhibitor of Akt, Synergizes with Gefitinib against Malignant Glioma via Modulating Both Autophagy and Apoptosis
- (2011) Y. Cheng et al. MOLECULAR CANCER THERAPEUTICS
- Targeting the Phosphoinositide-3 (PI3) Kinase Pathway in Breast Cancer
- (2011) J. Baselga ONCOLOGIST
- Synergistic Activity of Sorafenib and Sulforaphane Abolishes Pancreatic Cancer Stem Cell Characteristics
- (2010) Vanessa Rausch et al. CANCER RESEARCH
- A Subpopulation of CD26+ Cancer Stem Cells with Metastatic Capacity in Human Colorectal Cancer
- (2010) Roberta Pang et al. Cell Stem Cell
- Akt inhibitors in clinical development for the treatment of cancer
- (2010) Sumanta Kumar Pal et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- The CXCR4 antagonist AMD3100 suppresses hypoxia-mediated growth hormone production in GH3 rat pituitary adenoma cells
- (2010) D. Yoshida et al. JOURNAL OF NEURO-ONCOLOGY
- Pyrvinium, a Potent Small Molecule Wnt Inhibitor, Promotes Wound Repair and Post-MI Cardiac Remodeling
- (2010) Sarika Saraswati et al. PLoS One
- PTEN/PI3K/Akt Pathway Regulates the Side Population Phenotype and ABCG2 Activity in Glioma Tumor Stem-like Cells
- (2009) Anne-Marie Bleau et al. Cell Stem Cell
- Targeting the phosphoinositide 3-kinase pathway in cancer
- (2009) Pixu Liu et al. NATURE REVIEWS DRUG DISCOVERY
- Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
- (2008) Ann-Lii Cheng et al. LANCET ONCOLOGY
- Inhibition of CXCR4 activity with AMD3100 decreases invasion of human colorectal cancer cells in vitro
- (2008) Ji-Kun Li et al. WORLD JOURNAL OF GASTROENTEROLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started